MRSN - Mersana Therapeutics Q1 2024 Earnings Preview
2024-05-08 11:45:14 ET
More on Mersana Therapeutics
- Mersana Therapeutics, Inc. (MRSN) Q4 2023 Earnings Call Transcript
- Mersana Therapeutics GAAP EPS of -$0.16 in-line, revenue of $10.7M misses by $4.07M
- Mersana Therapeutics Q4 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Mersana Therapeutics
- Historical earnings data for Mersana Therapeutics